Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1244]
News [2383]
Articles [91]
Editorials [4]
Conferences [117]
elearning [25]
Analysing the efficacy of treatment through Response Evaluation Criteria in...
Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012
Treatment approaches for desmoid tumours
Dr Sylvie Bonvalot – Institut Gustave Roussy, Paris, France
Treatment approaches for desmoid tumours ( Dr Sylvie Bonvalot – Institut Gustave Roussy, Paris, France )
9 Oct 2012
Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype
Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal
Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype ( Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal )
9 Oct 2012
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast...
Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery ( Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy )
9 Oct 2012
Multidisciplinary benefits to radiotherapy
Prof Vincenzo Valentini – President of ESTRO
Multidisciplinary benefits to radiotherapy ( Prof Vincenzo Valentini – President of ESTRO )
9 Oct 2012
Treatment of ALK+ lung cancer with crizotinib, Profile 1007
Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012
Trametinib and dabrafenib combination therapy against metastatic melanoma
Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia
Trametinib and dabrafenib combination therapy against metastatic melanoma ( Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia )
8 Oct 2012
Treating liver metastases in colorectal cancer
Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany
Treating liver metastases in colorectal cancer ( Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany )
4 Oct 2012
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK...
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
30 Sep 2012
BRAF inhibitor dabrafenib alone vs combination with MEK1/2 inhibitor trametinib...
Dr Georgina Long - Melanoma Institute Australia, Sydney, Australia
BRAF inhibitor dabrafenib alone vs combination with MEK1/2 inhibitor trametinib for melanoma ( Dr Georgina Long - Melanoma Institute Australia, Sydney, Australia )
29 Sep 2012
Phase I and II trials focus on drug combination slowing development of...
Prof Yossef Yarden - Weizmann Institute of Science, Israel.
Phase I and II trials focus on drug combination slowing development of resistance inhibiting BRAF ( Prof Yossef Yarden - Weizmann Institute of Science, Israel. )
29 Sep 2012
Discussing the patient experience
Kicki Klaeson – Linkoping University, Sweden
Discussing the patient experience ( Kicki Klaeson – Linkoping University, Sweden )
21 Sep 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation